 AstraZeneca stock edged into breakout territory on Tuesday, a day after announcing its 1.8 billion plan to acquire CinCor Pharma. The post AstraZeneca Stock Nabs Breakout After 1.8 Billion CinCor Buyout appeared first on Investors Business Daily. 